2020
Neoadjuvant Chemotherapy or Chemoradiotherapy Does Not Increase Early and Late Post-operative Complication Rates Following Definitive Resection for Pancreatic Ductal Adenocarcinoma
Deig C, Stratton A, Trone K, Beneville B, Liu A, Kanwar A, Bassale S, Chen Y, Grossblatt-Wait A, Attia F, Sheppard B, Keith D, Chen E, Lopez C, Billingsley K, Gilbert E, Nabavizadeh N, Thomas C, Grossberg A. Neoadjuvant Chemotherapy or Chemoradiotherapy Does Not Increase Early and Late Post-operative Complication Rates Following Definitive Resection for Pancreatic Ductal Adenocarcinoma. International Journal Of Radiation Oncology • Biology • Physics 2020, 108: e606-e607. DOI: 10.1016/j.ijrobp.2020.07.1845.Peer-Reviewed Original ResearchPerioperative complication rates following neoadjuvant therapy in pancreatic adenocarcinoma.
Deig C, Beneville B, Liu A, Kanwar A, Grossblatt-Wait A, Sheppard B, Gilbert E, Lopez C, Billingsley K, Nabavizadeh N, Thomas C, Grossberg A. Perioperative complication rates following neoadjuvant therapy in pancreatic adenocarcinoma. Journal Of Clinical Oncology 2020, 38: 688-688. DOI: 10.1200/jco.2020.38.4_suppl.688.Peer-Reviewed Original ResearchPerioperative complication rateNeoadjuvant therapyComplication ratePancreatic adenocarcinomaNeo-CRTUpfront resectionUpfront surgeryHospital lengthExact testComparable perioperative complication ratesSignificant differencesAcademic tertiary referral centerInstitutional cancer registryMedian hospital lengthNeoadjuvant radiation therapyPatients Undergoing ResectionTotal neoadjuvant therapyPost-operative mortalityTertiary referral centerResectable pancreatic adenocarcinomaAdditional surgical riskFisher's exact testT-testStudent's t-testUndergoing resection
2011
Safety and efficacy of preoperative right portal vein embolization in patients at risk for postoperative liver failure following major right hepatectomy
Massimino K, Kolbeck K, Enestvedt C, Orloff S, Billingsley K. Safety and efficacy of preoperative right portal vein embolization in patients at risk for postoperative liver failure following major right hepatectomy. Hepato Pancreato Biliary 2011, 14: 14-19. PMID: 22151446, PMCID: PMC3252986, DOI: 10.1111/j.1477-2574.2011.00402.x.Peer-Reviewed Original ResearchConceptsRight portal vein embolizationPortal vein embolizationFuture liver remnantShort-term outcomesFLR volumeVein embolizationPreoperative right portal vein embolizationMajor right hepatectomyPost-embolization complicationsPostoperative liver failureRecords of patientsResults of embolizationDegree of hypertrophyHypertrophy rateRight hepatectomyLiver resectionMost complicationsOperative complicationsOperative resectionPatient demographicsComplication rateLiver failureLiver insufficiencyOperative outcomesLiver remnant
2010
Surgical treatment of intrahepatic cholangiocarcinoma: outcomes and predictive factors
Ellis M, Cassera M, Vetto J, Orloff S, Hansen P, Billingsley K. Surgical treatment of intrahepatic cholangiocarcinoma: outcomes and predictive factors. Hepato Pancreato Biliary 2010, 13: 59-63. PMID: 21159105, PMCID: PMC3019543, DOI: 10.1111/j.1477-2574.2010.00242.x.Peer-Reviewed Original ResearchConceptsOverall survival rateIntrahepatic cholangiocarcinomaR0 resectionSurgical treatmentR1/R2 resectionResectable intrahepatic cholangiocarcinomaPostoperative liver failureMainstay of treatmentOptimal patient selectionPostoperative complication rateKaplan-Meier methodCox hazard modelPreoperative hypoalbuminaemiaReplete patientsR2 resectionSurgical mortalityComplication rateSurgical resectionSurgical therapyWorse survivalClinicopathologic characteristicsLiver failureOperative detailsPrognostic factorsRecurrence outcomes